A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions

NCT ID: NCT07042191

Last Updated: 2025-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-09

Study Completion Date

2027-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall goal of this research program is to address financial toxicity through the development, testing, and implementation of a multi-level communication intervention. If successful, this intervention could be a companion intervention for Cancer providers in combination with the already in testing DISCO app (Discussions of Cost App) for patients. Participants will:

* complete a baseline survey
* attend two one on one meetings, one as part of the development and the second as part of the pilot testing of the intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

20 Wayne State University (WSU)/Karmanos Cancer Institute (KCI) oncology care providers (e.g., medical oncologists, nurses, social workers, APP) who treat patients at the KCI Detroit and Farmington Hills clinics where patients are treated for cancer will be recruited. At least two providers from each discipline who treat various cancer types will be included. The study will be discussed at clinic program meetings and then interested providers will be consented. Providers who consent will agree to 1) complete a baseline survey, and 2) attend two one-on-one meetings, one as a part of the DISCO (Discussion of Cost) Provider development (Aim 1) and the second as a part of the DISCO Provider pilot-testing (Aim 2).

To achieve Aim 1, participants will be asked to complete a survey eliciting their demographic and professional characteristics prior to interviews. Then, during one-on-one interviews, which will be audio recorded and subsequently transcribed, the investigators will present the DISCO Provider wireframes and ask participants to provide feedback on the planned content, organization, and implementation. The Investigators will also present participants with strategies identified from research on how to initiate, respond to, and effectively discuss cost concerns. Investigators will ask participants about ideas for website design and training intervention implementation. Participants will be asked to complete a needs assessment interview about their use of digital support tools.

To achieve Aim 2 and pilot test DISCO Provider, participants will again meet one-on-one with the Investigators. Investigators will ask participants to provide feedback on the acceptability and usability of the working version of DISCO Provider, whether participants think it is useful for training providers to discuss cost, if the strategies suggested will likely be effective, and suggestions for improvement. Meetings will be audio recorded, transcribed, and analyzed using similar methods as those in Aim 1

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Financial Toxicity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DISCO (Discussions of Cost) Provider Companion Intervention

Providers of Cancer patients at Karmanos Cancer Institute will use the DISCO (Discussion of Cost) provider communication intervention to assess its feasibility, acceptability, and usability

Group Type EXPERIMENTAL

Disco (Discussion of Cost) Provider Companion Intervention

Intervention Type BEHAVIORAL

A communication intervention for providers to assess financial toxicity in Cancer patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Disco (Discussion of Cost) Provider Companion Intervention

A communication intervention for providers to assess financial toxicity in Cancer patients

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Oncology care providers at Karmanos Cancer Institute (KCI)/Wayne State University(WSU) including medical oncologists, nurses, social workers and advance practice providers who treat cancer patients at KCI Detroit or Farmington Hills clinics

Exclusion Criteria

\-
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Barbara Ann Karmanos Cancer Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lauren Hamel

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lauren M Hamel, PhD

Role: PRINCIPAL_INVESTIGATOR

Wayne State University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Karmanos Cancer Institute

Detroit, Michigan, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lauren M Hamel, PhD

Role: CONTACT

13135769672

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lauren M Hamel, PhD

Role: primary

13135769672

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-085

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Assessing the Time Demands of Cancer
NCT05708703 ACTIVE_NOT_RECRUITING
Proactive Costs of Care Study
NCT07217262 NOT_YET_RECRUITING NA